ACIM
TMO icon

Azimuth Capital Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Azimuth Capital Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1M Sell
22,225
-1,759
-7% -$844K 0.38% 85
2026
Q1 		$11.8M Buy
23,984
+20,701
+631% +$11.2M 0.44% 78
2025
Q4 		$1.9M Sell
3,283
-50
-2% -$28.3K 0.07% 189
2025
Q3 		$1.62M Sell
3,333
-30
-0.9% -$14K 0.06% 188
2025
Q2 		$1.36M Buy
3,363
+200
+6% +$83.6K 0.05% 197
2025
Q1 		$1.57M Sell
3,163
-21
-0.7% -$11.4K 0.06% 189
2024
Q4 		$1.66M Hold
3,184
– – 0.06% 188
2024
Q3 		$1.97M Buy
3,184
+451
+17% +$267K 0.08% 186
2024
Q2 		$1.51M Buy
2,733
+81
+3% +$46.4K 0.06% 197
2024
Q1 		$1.54M Sell
2,652
-80
-3% -$44.9K 0.06% 194
2023
Q4 		$1.45M Sell
2,732
-14,149
-84% -$6.85M 0.07% 196
2023
Q3 		$8.54M Sell
16,881
-8,913
-35% -$4.75M 0.42% 75
2023
Q2 		$13.5M Buy
25,794
+150
+0.6% +$80.9K 0.64% 50
2023
Q1 		$14.8M Buy
25,644
+23,089
+904% +$13M 0.73% 41
2022
Q4 		$1.41M Sell
2,555
-110
-4% -$58.3K 0.07% 207
2022
Q3 		$1.35M Sell
2,665
-5
-0.2% -$2.8K 0.07% 202
2022
Q2 		$1.45M Buy
+2,670
New +$1.47M 0.07% 205

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Azimuth Capital Investment Management's TMO Position: Q2 2026 in Review

Azimuth Capital Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 7.3% in Q2 2026, selling an estimated $844K and leaving 22,225 shares worth $11.1M. The position accounts for 0.38% of the portfolio, ranked #85.

Azimuth Capital Investment Management first reported a position in TMO in Q2 2022 and has held it in 17 quarters since. The position peaked at $14.8M in Q1 2023. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Azimuth Capital Investment Management held 22,225 shares of Thermo Fisher Scientific worth $11.1M as of Q2 2026.
  • Azimuth Capital Investment Management sold 1,759 Thermo Fisher Scientific shares in Q2 2026, an estimated $844K.
  • Thermo Fisher Scientific made up 0.38% of Azimuth Capital Investment Management's portfolio in Q2 2026, its #85 holding.
  • Azimuth Capital Investment Management first reported a position in Thermo Fisher Scientific in Q2 2022 and has held it in 17 quarters since.
  • Azimuth Capital Investment Management's Thermo Fisher Scientific position peaked at $14.8M in Q1 2023.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Azimuth Capital Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.